Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-04-05

Clinical Trial Update: Recurrent Glomerulonephritis After Renal Transplantation

View source ↗

Summary

A completed clinical trial examining recurrent glomerulonephritis after renal transplantation is reported, with Istanbul University listed as sponsor.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Istanbul University | Conditions: Glomerulonephritis | Status: COMPLETED